Articles published in Nuclear Medicine & Radiation Therapy have been cited by esteemed scholars and scientists all around the world.
Nuclear Medicine & Radiation Therapy has got h-index 12, which means every article in Nuclear Medicine & Radiation Therapy has got 12 average citations.
Following are the list of articles that have cited the articles published in Nuclear Medicine & Radiation Therapy.
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
Year wise published articles |
63 | 62 | 11 | 17 | 49 |
Year wise citations received |
69 | 80 | 82 | 74 | 61 |
| Journal total citations count | 706 |
| Journal impact factor | 1.01 |
| Journal 5 years impact factor | 1.8 |
| Journal cite score | 1.98 |
| Journal h-index | 12 |
| Journal h-index since 2018 | 9 |
Estey EH (2012) Intensity of conditioning for allogeneic haemopoetic cell transplantation. Lan Oncol 13: 966-968. |
|
Siddiqui A, Jeevani T, Naga Anusha P, Hima Bindu A (2011) Stem cell therapy for liver diseases. J Stem Cell Res Ther 1: 2. |
|
Shcherbinin S, Grimes J, Bator A, Cwikla JB, Celler A (2013) Three-dimensional personalized dosimetry for 188Re liver selective internal radiation therapy based on quantitative post-treatment SPECT studies. Phys Med Biol 59: 119. |
|
Pasciak AS, Bourgeois AC, Bradley YC (2014) A comparison of techniques for 90Y PET/CT image-based dosimetry following radioembolization with resin microspheres. Fron Oncol 4: 121. |
|
Siddiqui A, Jeevani T, Naga Anusha P, Hima Bindu A (2011) Stem cell therapy for liver diseases. J Stem Cell Res Ther, 1: 2. |
|
Nishant T, Bindu HK, Kumar SD, Kumar AR (2011) Pharmacogenomics-Personalized treatment of cancer, diabetes and cardiovascular diseases. J Pharmacogen Pharmacoproteo 2: 107. |
|
Pasciak AS, Bourgeois AC, McKinney JM, Chang TT, Osborne DR, et al. (2014) Radioembolization and the dynamic role of 90Y PET/CT. Fron Oncol 4: 38. |
|
Cosimelli M (2012) The evolution of radioembolisation. Lan Oncol 13: 965. |
|
Andrew K (2014) Radioembolization of hepatic tumors. J Gastroint Oncol 5 178-189. |
|
D’Arienzo M, Chiaramida P, Chiacchiararelli L, Coniglio A, Cianni R, et al. (2012). 90Y PET-based dosimetry after selective internal radiotherapy treatments. Nucl Med Comm 33: 633-640. |
|
Naga Anusha P (2011) Risk Factors in Hepatocellular Carcinoma. J Cancer Sci Ther S17. |
|
Kao YH, Tan AEH, Burgmans MC, Irani FG, Khoo LS, et al. (2012) Image-guided personalized predictive dosimetry by artery-specific SPECT/CT partition modeling for safe and effective 90Y radioembolization. J Nucl Med 53: 559-566. |
|
Mahnken AH (2015) 90Y-glass microspheres for hepatic neoplasia. Fut Oncol 11: 1343-1354. |
|
Vilgrain V, Abdel-Rehim M, Sibert A, Ronot M (2014) Clinical studies in hepatocellular carcinoma. Fut Oncol 10:13-16. |
|
Siddiqui A, Jeevani T, Anusha NP, Bindu HA (2011) Stem cell therapy for liver diseases. J Stem Cell Res Ther, 1:2. |
|
Sharma RA (2012) Synergy of yttrium-90 microspheres therapy with radiosensitising chemotherapy. Eur J Cancer Suppl 10: 4-6. |
|
Lee EW, Thakor AS, Tafti BA, Liu DM (2015) Y90 selective internal radiation therapy. Surgical oncology clinics of North America, 24: 167-185. |
|
Siddiqui A, Jeevani T, Naga Anusha P, Hima Bindu A (2011) Stem cell therapy for liver diseases. J Stem Cell Res Ther 1: 2. |
|
van Hazel GA, Heinemann V, Sharma NK, Findlay MP, Ricke J, et al. (2016) SIRFLOX: Randomized phase III trial comparing first-line mFOLFOX6 (plus or minus bevacizumab) versus mFOLFOX6 (plus or minus bevacizumab) plus selective internal radiation therapy in patients with metastatic colorectal cancer. J Clin Oncol 34:1723-1731. |
|
Nishant T, Bindu HK, Kumar SD, Kumar AR (2011). Pharmacogenomics-Personalized treatment of cancer, diabetes and cardiovascular diseases. J Pharmacogenomics Pharmacoproteomics, 2, 107. |
|
Nuclear Medicine & Radiation Therapy received 706 citations as per Google Scholar report
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 